The Spanish vaccine against Hipra’s coronavirus will have to wait longer for Europe to decide whether to approve it. The European Medicines Agency (EMA) has requested more data from the laboratory as ‘Five days’ and ‘ABC’ have advanced.
The Minister of Science and Innovation, Diana Morant, announced in July that the decision of the European Medicines Agency (EMA) would come “in a few days”, but this has not been the case. Also in September, Elia Torroelladirector of R&D and records at Hipra, explained in one event organized by EL PERIÓDICO that the pharmacist was running out collect all information requested by the European Medicines Agency (EMA) for final approval of this new injection against the coronavirus.
However, ‘Cinco días’ points out, the problem that the Catalan laboratory has faced affects manufacturing and quality, according to health sources. This pharmaceutical company specializes in medicines for animal use (and is, in fact, very powerful in veterinary vaccines), but in this case it is its first product for human use, which could have caused the company to took longer to adjust processes.